Crimson Tide PLC mpro5 healthcare update
July 05 2018 - 3:38AM
RNS Non-Regulatory
TIDMTIDE
Crimson Tide PLC
05 July 2018
Crimson Tide plc ("Crimson Tide" or the "Company")
Continued investment in mpro5 for healthcare sees GCloud
accreditation contract awards.
Crimson Tide is pleased to announce it has continued to add
subscribers in the healthcare sector from its investments in
R&D and marketing. Critical to our growth in the UK healthcare
sector and specifically the public bodies responsible for delivery,
it is also with great pleasure that the Company announces that
mpro5 has been accepted to GCloud 10, the government marketplace
for applications.
A global healthcare organisation has completed a second
successful pilot of mpro5 for the identification and reporting of
falsified and fraudulent medication. These pilots have been carried
out in emerging nations where the effectiveness of contraceptives
and anti-malarial medicines are critical to the economic and social
development of the country as a whole. mpro5 has positively
detected multiple instances of falsified medicine in the pilot
areas. The Company is hopeful that further collaboration could lead
to full rollouts in the pilot countries and other uses of mpro5 are
under discussion.
Crimson Tide is in the process of adding a new biometric time
and attendance module to mpro5 for a NHS trust in the North West of
England, leveraging scanning capabilities to guarantee correct
identification of individuals arriving on site.
The Company has also won a contract to aid AVM Services, which
operates within Cambridge University Hospitals NHS Foundation
Trust, with decontamination activities which are conducted in
accordance with standardised UK regulatory procedures. mpro5 allows
the scheduling of regular tasks in respect of porous loads and
instruments including sterilizers, disinfectors and endoscopes. The
commissioning of decontamination equipment is achieved through an
mpro5 workflow that automatically awards the relevant compliance or
commissioning document based on a complex scoring method.
A variety of our existing facilities management clients have
continued the rollout of 49 point NHS cleaning compliance checks
adding an increasing number of healthcare facilities to the
locations where mpro5 is in daily use.
Crimson Tide's Executive Chairman, Barrie Whipp commented. "It
is pleasing to hear of the NHS commitment to mobile applications
for patients. mpro5 is a tactical solution to healthcare scenarios
for not only patients, but clinicians and organisations that
participate in the healthcare supply chain. We are now GCloud
approved allowing us to push on with our investments and bring real
change to processes in the state and private sector, locally and
internationally"
-- ends --
For further information:
Crimson Tide plc Barrie Whipp / Luke Jeffrey / Steve Goodwin
01892 542 444
Arden Partners plc (Nomad/Broker) Steve Douglas / Dan
Gee-Summons 020 7614 5900
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAEAXXSEDKPEEF
(END) Dow Jones Newswires
July 05, 2018 03:38 ET (07:38 GMT)
Crimson Tide (LSE:TIDE)
Historical Stock Chart
From Apr 2024 to May 2024
Crimson Tide (LSE:TIDE)
Historical Stock Chart
From May 2023 to May 2024